| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 08/16/2001 | WO2001058855A1 Use of androgen receptor suppressors |
| 08/16/2001 | WO2001058854A1 A topical antiandrogen for hair loss and other hyperandrogenic conditions |
| 08/16/2001 | WO2001058853A1 Dehydroamino acids |
| 08/16/2001 | WO2001058852A2 (r)-2-aryl-propionamides, useful in the inhibition of il-8-induced chemiotaxis of neutrophils |
| 08/16/2001 | WO2001058483A2 METHODS FOR THE PREVENTION AND TREATMENT OF INFECTIONS USING ANTI-C3b(i) ANTIBODIES |
| 08/16/2001 | WO2001058473A1 Method of treating or inhibiting cellular injury or cell death |
| 08/16/2001 | WO2001058452A1 Thermal ablation of tissue |
| 08/16/2001 | WO2001058442A1 An essential constituent and method of use for maintaining hair coloration or reversing hair discoloration |
| 08/16/2001 | WO2001058412A2 Extracts from residues left in the production of wine |
| 08/16/2001 | WO2001058283A1 Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability or undesired permeability of the intestinal wall |
| 08/16/2001 | WO2001010842A3 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 08/16/2001 | WO2001010413A3 Periodic structures comprising lipids, polyelectrolytes, and structures-inducing soluble oligovalent linkers |
| 08/16/2001 | WO2001010381A3 Methods for treating or preventing pain and anxiety |
| 08/16/2001 | WO2001009096A3 Potassium channel openers |
| 08/16/2001 | WO2001007628A3 Human synthetases |
| 08/16/2001 | WO2001007595A3 Novel fibroblast growth factor and nucleic acids encoding same |
| 08/16/2001 | WO2001002569A3 Human immune response molecules |
| 08/16/2001 | WO2000066106A3 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
| 08/16/2001 | WO2000058506A3 Susceptibility to psoriasis |
| 08/16/2001 | US20010014689 Nervous system disorders |
| 08/16/2001 | US20010014442 Containing tyrosine and,or phenylalanine |
| 08/16/2001 | US20010014356 Silica coated zinc oxide adsorber for rough skin sensitivity |
| 08/16/2001 | US20010014311 External preparation for skin |
| 08/16/2001 | EP1144678A3 Susceptibility to psoriasis |
| 08/16/2001 | EP1143946A3 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
| 08/16/2001 | EP1123927A1 Process for the preparation of bis-(4-amino-1-pyridinium)-alkanes |
| 08/16/2001 | EP1123692A2 Use of polyaminoacid derivatives for the treatment of Seborrhea and related cutaneous disorders |
| 08/16/2001 | EP1123392A1 Prv-1 gene and the use thereof |
| 08/16/2001 | EP1123297A1 New compounds, their preparation and use |
| 08/16/2001 | EP1123296A1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION |
| 08/16/2001 | EP1123295A1 Bicyclic nitrogen heterocycles |
| 08/16/2001 | EP1123292A1 New compounds, their preparation and use |
| 08/16/2001 | EP1123283A1 Thiazole-derivatives |
| 08/16/2001 | EP1123279A1 New compounds, their preparation and use |
| 08/16/2001 | EP1123276A1 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 08/16/2001 | EP1123274A1 Substituted phenyl derivatives, their preparation and use |
| 08/16/2001 | EP1123269A1 New compounds, their preparation and use |
| 08/16/2001 | EP1123268A1 New compounds, their preparation and use |
| 08/16/2001 | EP1123267A1 New compounds, their preparation and use |
| 08/16/2001 | EP1123110A1 Compositions and methods for promoting tissue repair using heat shock proteins |
| 08/16/2001 | EP1123101A1 Fluticasone lotion having improved vasoconstrictor activity |
| 08/16/2001 | EP1123092A2 Fumaric acid microtablets |
| 08/16/2001 | EP1123091A1 Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use |
| 08/16/2001 | EP1123086A2 Artificial antigen-specific cells and related methods |
| 08/16/2001 | EP1123082A1 Preparations for topical application of substances having antiandrogenic effect |
| 08/16/2001 | EP1123072A1 Anti-inflammatory and antimicrobial uses for bioactive glass compositions |
| 08/16/2001 | EP0964681B1 Anticonvulsant derivatives useful in treating psoriasis |
| 08/16/2001 | EP0882033B1 Benzofuran-acrylic acid derivatives and their use as modulators of rxrs or rars receptors |
| 08/16/2001 | EP0725634B1 Plaster for the treatment of nail mycoses |
| 08/16/2001 | EP0694307B1 Atopic disease remedy |
| 08/16/2001 | EP0558677B1 Biologically active amines |
| 08/16/2001 | DE19960504A1 Regenerationsmittel Regenerant |
| 08/16/2001 | CA2800450A1 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | CA2400699A1 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 08/16/2001 | CA2400488A1 Methods for the prevention and treatment of infections using anti-c3b(i) antibodies |
| 08/16/2001 | CA2399799A1 2-phenylcarbamoyl-benzimidazoles |
| 08/16/2001 | CA2399795A1 2-carboxamide-benzimidazoles useful in the treatment and prevention of ischemic reperfusion injury |
| 08/16/2001 | CA2399623A1 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 08/16/2001 | CA2399436A1 Method of treating or inhibiting cellular injury or cell death |
| 08/16/2001 | CA2399387A1 Heterologous polypeptide of the tnf family |
| 08/16/2001 | CA2399148A1 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | CA2399136A1 1h-imidazopyridine derivatives |
| 08/16/2001 | CA2398984A1 Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability or undesired permeability of the intestinal wall |
| 08/16/2001 | CA2398775A1 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 08/16/2001 | CA2398170A1 An essential constituent and method of use for maintaining hair coloration or reversing hair discoloration |
| 08/16/2001 | CA2397993A1 Dehydroamino acids |
| 08/16/2001 | CA2395648A1 Oxazolidinone thioamides with piperazine amide substituents |
| 08/15/2001 | CN1308632A 'Beta'-carboline compound |
| 08/15/2001 | CN1308616A Non-peptidyl inhibitors and VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory disease |
| 08/15/2001 | CN1308609A Method of locking 1 & alpha, -OH of vitamin d compounds in axial orientation |
| 08/15/2001 | CN1308541A Extracts of zanthoxylum bungeanum, pharmaceuti-cal and cosmetic formulations containing them |
| 08/15/2001 | CN1308537A Steroid-containing cataplasms and process for producing the same |
| 08/15/2001 | CN1308059A Colchicine derivative and is treatment use |
| 08/15/2001 | CN1307898A Chinese medicine liniment for treating acne fast |
| 08/15/2001 | CN1307868A Bactericidal medicine |
| 08/15/2001 | CN1307864A Skin-protecting face nursing liquid |
| 08/15/2001 | CN1069539C Medicinal composition for curing acne and folliculitis and its preparation method |
| 08/15/2001 | CN1069537C Medicine for weight-reducing and beautifying |
| 08/15/2001 | CN1069525C Turtle oil, soft-shelled turtle oil compositions and the preparation thereof |
| 08/14/2001 | US6274618 Administering (-)-cis-6-phenyl-5-(4-(2-pyrrolidin-1-yl-ethoxy)-phenyl)-5,6,7,8 -tetrahydronphthalen-2-ol to treat vaginal dryness, itching, or painful intercourse |
| 08/14/2001 | US6274616 ((3-(2-amino-1,2-dioxoethyl)-1-((1,1'-biphenyl)-3-ylmethyl)-2 -methyl-1h-indol-4-yl)oxy)acetic acid n,n-diethylglycolamidoester used for inhibiting human non-pancreatic secretory phopholipase a2 mediated release of |
| 08/14/2001 | US6274590 Administering 3,4-diarylthiophene derivative to treat eczema, burns, psoriasis, and dermatitis |
| 08/14/2001 | US6274588 4-phenyl-pyrimidine derivatives |
| 08/14/2001 | US6274577 Autoimmune diseases; antiinflammatory agents |
| 08/14/2001 | US6274572 Pregnane derivatives with no alpha-17 substitutent, their medicinal use, manufacturing method and its intermediaries and related compounds |
| 08/14/2001 | US6274364 An isolated protease present in healthy stratum corneum; therapy and treatment of afflictions such as eczema, rosacea, psoriasis, lichens, severe pruritus and ichthyosis |
| 08/14/2001 | US6274151 Combining cosmetic agent and excipient with n-palmitoyl proline and n-palmitoyl glutamic acid or the sodium or magnesium salt; or n-palmitoyl proline, n-palmitoyl glutamic acid and n-palmitoyl sarcosine or the sodium or magnesium salt |
| 08/14/2001 | CA2150871C Cosmetic sunscreens made of a synergetic mix of filters and their uses |
| 08/09/2001 | WO2001057267A1 Methods and materials relating to cub domain polypeptides and polynucleotides |
| 08/09/2001 | WO2001057261A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 08/09/2001 | WO2001057205A1 Selective killing of cells by activation of double-stranded rna dependent protein kinase-pkr |
| 08/09/2001 | WO2001057079A2 C1 inhibitor produced in the milk of transgenic mammals |
| 08/09/2001 | WO2001057067A1 Ligand for vascular endothelial growth factor receptor |
| 08/09/2001 | WO2001057036A1 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes |
| 08/09/2001 | WO2001057034A1 3-aminopyrazole inhibitors of cyclin dependent kinases |
| 08/09/2001 | WO2001057026A1 Compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them |
| 08/09/2001 | WO2001057025A1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes |
| 08/09/2001 | WO2001057023A1 Heterocyclic amide derivatives |
| 08/09/2001 | WO2001057022A2 Pyrazole compositions useful as inhibitors of erk |
| 08/09/2001 | WO2001057008A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors |